| Financial Year |
March 31 2023 |
| Monetary Funds |
1,234,597,665.81 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
336,462,870.47 |
| Accounts Receivable |
168,663,167.56 |
| Advances to Suppliers |
189,104,192.53 |
| Other Receivables |
81,639,217.08 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
468,336,900.69 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
55,246,862.93 |
| Total Current Assets |
2,976,158,466.10 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
118,627,357.47 |
| Investment Properties |
-- |
| Fixed Assetes |
3,336,699,869.48 |
| Under-construction Projects |
1,855,074,890.53 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
834,778,480.59 |
| R&D expenses |
367,001.88 |
| Goodwill |
104,631,021.25 |
| Long-Term Deferred and Prepaid Expenses |
51,572,458.90 |
| Deferred Income Tax Assets |
78,169,912.16 |
| Other Non-Current Assets |
124,667,135.87 |
| Sub-Total of Non-Current Assets |
6,510,124,246.90 |
| Total Assets |
9,486,282,713.00 |
| Short-Term Loans |
186,636,496.04 |
| Trading Financial liabilities |
-- |
| Notes Payable |
393,872,475.32 |
| Accounts Payable |
673,115,994.89 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
92,611,628.16 |
| Taxes Payable |
63,927,642.14 |
| Interest Payable |
-- |
| Dividend Payable |
54.42 |
| Other payables |
371,662,105.53 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
26,547,777.78 |
| Other Current Liabilities |
128,784,917.40 |
| Sub-Total of Current Liabilities |
2,108,793,609.35 |
| Long-term Loans |
349,222,481.95 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
58,500,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
400,000.00 |
| Deferred Income Tax Liabilities |
56,054,490.05 |
| Other Non-Current Liabilities |
3,430,000.00 |
| Sub-Total of Non-Current Liabilities |
546,006,440.16 |
| Total Liabilities |
2,654,800,049.51 |
| Paid-In Capital(Or Share Stock) |
1,474,480,490.00 |
| Capital Surplus |
3,021,498,013.51 |
| Surplus Reserve |
120,664,304.71 |
| LESS:Treasury Stock |
41,759,600.00 |
| Undistributed Profits |
1,854,589,776.16 |
| Minority Stockholder's Interest |
403,400,834.30 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,428,081,829.19 |
| Owner's Equity（Stockholder's Equity） |
6,831,482,663.49 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,486,282,713.00 |
